Abstract
Chronic head and facial pain is a multifaceted experience for patients, as it can pervasively affect the ability to function and ultimately hinder quality of life. Multidisciplinary approaches, including psychological and psychiatric interventions, for headache and facial pain are often necessary for successful treatment. Mood and anxiety symptoms, as well as deleterious health behaviors, can derail appropriate self-management, which then negatively affects medical management. This chapter will review cognitive-behavioral interventions, relaxation/biofeedback training, operant learning theory, the role of family support, and psychotropic medication options that can enhance health coping and effective head and facial pain management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hamelsky SW, Lipton RB. Psychiatric comorbidities of migraine. Headache. 2006;46:1327–33. https://doi.org/10.1111/j.1526-4610.2006.00576.x.
Harris P, Loveman E, Clegg A, et al. Systematic review of cognitive behavioral therapy for the management of headaches and migraines in adults. Br J Pain. 2015;9(4):213–24. https://doi.org/10.1177/2049463715578291.
Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66. https://doi.org/10.1037/a0035747.
Moreira FP, Cardoso TA, Mondin TC, et al. The effect of proinflammatory cytokines in cognitive behavioral therapy. J Neuroimmunol. 2015;285:143–6.
Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9(5):745–58. https://doi.org/10.1586/ERN.09.34.
Borkum JM. Maladaptive cognitions and chronic pain: epidemiology, neurobiology, and treatment. J Ration Emot Cogn Behav Ther. 2010;28:4–24. https://doi.org/10.1007/s10942-010-0109-x.
Singh NN, Sahota P. Sleep-related headache and its management. Curr Treat Options Neurol. 2013;15:704–22. https://doi.org/10.1007/s11940-013-0258-1.
Mitchell MD, Gehrman P, Umschied CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40–51. http://www.biomedcentral.com/1471-2296/13/40
Schramm SH, Moebus S, Lehmann N, et al. The association between stress and headache: a longitudinal population-based study. Cephalalgia. 2015;35(10):853–63. https://doi.org/10.1177/0333102414563087.
Lipton RB, Buse DC, Hall CB, et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82:1395–401.
McGrady AV, Andrasik F, Davies T, et al. Psychophysiologic therapy for chronic headache in primary care. J Clin Psychiatry. 1999;1(4):96–102.
Rausa M, Palomba D, Cevoli S. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17:87–95. https://doi.org/10.1186/s10194-016-0679-9.
Fordyce WE. Behavioral methods for chronic pain and illness. St Louis: C.V. Mosby; 1976.
Gatzounis R, Schrooten MGS, Crombez G, et al. Operant learning theory in pain and chronic pain rehabilitation. Curr Pain Headache Rep. 2012;16:117–26. https://doi.org/10.1007/s11916-012-0247-1.
Block AR, Kremer EF, Gaylor M. Behavioral treatment of chronic pain: the spouse as a discriminative cue for pain behavior. Pain. 1980;9:243–52.
Kerns RD, Haythornwaithe J, Southwick S, et al. The role of marital interaction in chronic pain and depressive symptom severity. J Psychosom Res. 1990;34(4):401–8.
Merikangas KR, Merikangas JR. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Biol Psychiatry. 1995;38(9):603–10.
Kuritzky A, Zoldan Y, Melamed E. MAO B inhibitor, is not effective in the prophylaxis of migraine without aura: an open study. Headache. 1992;32(8):416.
Doyle Strauss L, Weizenbaum E, Loder EW, et al. Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study. Headache. 2016;56(10):1626–34.
Linde M, Steiner TJ, Chisholm D. Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain. 2015;16:15.
Powers SW, Kashikar-Zuck SM, Allen JR. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.
Kalita J, Bhoi SK, Misra UK. Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial. Acta Neurol Scand. 2013;128(1):65–72.
Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1–59.
Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain. 2012;13(1):53–9.
Domingues RB, Silva AL, Domingues SA, et al. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009;67(4):973–7.
Lampl C, Huber G, Adl J, Luthringshausen G, et al. Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors. Eur J Neurol. 2009;16(8):943–8.
Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005;20(3):CD002919.
Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol. 2009;32(5):254–8.
Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache. 1992;32(2):101–4.
Saper JR, Silberstein SD, Lake AE, et al. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34(9):497–502.
Bulut S, Berilgen MS, Baran A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg. 2004;107(1):44–8.
Young WB, Bradley KC, Anjum MW, et al. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Headache. 2013;53(9):1430–7.
Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008;69(9):1449–54.
Autret A, Valade D, Debiais S. Placebo and other psychological interactions in headache treatment. J Headache Pain. 2012;13:191–8. https://doi.org/10.1007/s10194-012-0422-0.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rush, T.E., Goforth, H.W. (2018). Psychological and Psychiatric Treatment of Chronic Head and Face Pain. In: Suen, J., Petersen, E. (eds) Diagnosis and Management of Head and Face Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-90999-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-90999-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90998-1
Online ISBN: 978-3-319-90999-8
eBook Packages: MedicineMedicine (R0)